×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Orchid Pharma Limited | 1888.59 | 181.97 | 1729.29 | 3.59 | 3,582 | 42.0 |
| GUFIC BIOSCIENCES LTD. | 2278.06 | 120.73 | 2269.11 | 1.2 | 3580 | 57.9 |
| UNICHEM LABORATORIES LTD. | 3885.0 | -18.5 | 3842.5 | -0.26 | 3539 | 28.3 |
Orchid Pharma Limited, with Security Code 524372, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 209.9 | 182.9 | 198.8 | 220.6 | 217.1 | 244.4 | 222.7 | 217.3 | 237.5 | 172.9 |
| Expenses | 170.2 | 160.8 | 175.1 | 184.7 | 188.2 | 211.2 | 193.1 | 191.0 | 203.1 | 158.8 |
| Operating Profit | 39.7 | 22.1 | 23.7 | 35.9 | 28.9 | 33.2 | 29.6 | 26.4 | 34.4 | 14.2 |
| OPM % | 18.91% | 12.11% | 11.92% | 16.28% | 13.32% | 13.6% | 13.28% | 12.13% | 14.49% | 8.2% |
| Other Income | 40.9 | 1.9 | 8.2 | 7.4 | 12.9 | 7.8 | 8.0 | 9.9 | 6.3 | 15.9 |
| Interest | 7.5 | 5.5 | 3.8 | 3.5 | 3.4 | 3.5 | 3.3 | 3.8 | 4.0 | 3.3 |
| Depreciation | 7.2 | 7.7 | 7.8 | 9.3 | 8.4 | 8.4 | 8.6 | 8.6 | 8.8 | 8.7 |
| Profit before tax | 26.7 | 10.8 | 20.2 | 30.5 | 30.0 | 29.1 | 25.6 | 23.9 | 27.9 | 18.2 |
| Tax % | 0% | 0% | 0% | 0% | 10.8% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 64.9 | 10.8 | 20.2 | 30.5 | 33.2 | 29.1 | 25.6 | 23.9 | 27.8 | 18.2 |
| EPS in Rs | 15.89 | 5.28 | 4.4 | 6.42 | 6.86 | 5.74 | 5.05 | 4.71 | 0 | 3.59 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 159.8 | 209.9 | 182.9 | 198.8 | 220.6 | 217.1 | 244.4 | 222.7 | 217.3 | 237.5 |
| Expenses | 146.1 | 170.2 | 162.1 | 175.7 | 186.0 | 188.7 | 211.9 | 192.4 | 192.7 | 209.4 |
| Operating Profit | 13.7 | 39.7 | 20.8 | 23.1 | 34.6 | 28.4 | 32.5 | 30.3 | 24.7 | 28.1 |
| OPM % | 8.55% | 18.9% | 11.36% | 11.62% | 15.7% | 13.07% | 13.29% | 13.62% | 11.36% | 11.82% |
| Other Income | 8.9 | 40.9 | 1.9 | 8.4 | 7.6 | 13.4 | 7.6 | 7.5 | 8.5 | 3.9 |
| Interest | 7.7 | 7.5 | 5.5 | 3.8 | 3.5 | 3.5 | 3.5 | 3.3 | 3.8 | 3.9 |
| Depreciation | 8.2 | 7.2 | 7.7 | 7.8 | 9.3 | 8.4 | 8.4 | 8.6 | 8.6 | 8.9 |
| Profit before tax | 6.7 | 26.7 | 9.4 | 19.8 | 29.4 | 29.8 | 28.1 | 25.9 | 20.8 | 19.2 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 10.3% | -0.5% | 0% | 0% | 0% |
| Net Profit | 7.6 | 59.1 | 9.4 | 19.8 | 29.4 | 33.0 | 29.4 | 27.2 | 20.8 | 22.3 |
| EPS in Rs | 1.86 | 14.49 | 1.85 | 4.3 | 6.18 | 6.81 | 5.79 | 5.37 | 4.1 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -8% |
| 5 Years: | 7% |
| 3 Years: | 22% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 22% |
| 3 Years: | 41% |
| TTM: | 27% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 0% |
| 3 Years: | 35% |
| 1 Year: | -34% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -8% |
| 5 Years: | 6% |
| 3 Years: | 22% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 22% |
| 3 Years: | 41% |
| TTM: | 29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 0% |
| 3 Years: | 35% |
| 1 Year: | -34% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|